(Q38108516)

29 August 2017

title

Diphtheria toxin-based targeted toxin therapy for brain tumors (English)

1 reference

29 August 2017

2

Daniel A Vallera

1 reference

29 August 2017

Yan Michael Li

1

1 reference

29 August 2017

Walter A Hall

series ordinal

3

1 reference

29 August 2017

publication date

22 May 2013

1 reference

Journal of Neuro-Oncology

29 August 2017

published in

1 reference

29 August 2017

volume

114

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

155-164

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-013-1157-8

29 August 2017

exact match

0 references

cites work

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Immunotoxin therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Immunotoxins and central nervous system neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Novel drug delivery strategies in neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Targeted toxins as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Molecular characterization of diphtheria toxin repressor (dtxR) genes present in nontoxigenic Corynebacterium diphtheriae strains isolated in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Clinical trials of targeted toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Cell surface receptors in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Immunotoxins in the treatment of hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Proteolysis and invasiveness of brain tumors: role of urokinase-type plasminogen activator receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Interleukin 13: a growth factor in hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

IL-4/IL-13 signaling beyond JAK/STAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Differential expression of interleukins IL-13 and IL-15 in normal ovarian tissue and ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Transferrin receptors in human tissues: their distribution and possible clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

A comprehensive outlook on intracerebral therapy of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

The EGFRvIII variant in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

A novel reduced immunogenicity bispecific targeted toxin simultaneously recognizing human epidermal growth factor and interleukin-4 receptors in a mouse model of metastatic breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Convection-enhanced delivery: neurosurgical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Assessment of a balloon-tipped catheter modified for intracerebral convection-enhanced delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Expression of Interleukin 13 Receptor in Glioma and Renal Cell Carcinoma: IL13Rα2 as a Decoy Receptor for IL13

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1157-8

Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.

21 January 2018

1 reference

12 December 2020

Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms

1 reference

12 December 2020

In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma

1 reference

12 December 2020

Interaction of diphtheria toxin with mammalian cell membranes

1 reference

12 December 2020

Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo

1 reference

12 December 2020

Immunotoxin treatment of brain tumors

1 reference

12 December 2020

Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin

1 reference

12 December 2020

Chemotherapy for malignant gliomas

1 reference

12 December 2020

Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin.

1 reference

12 December 2020

Selection and properties of a mouse L-cell transformant expressing human transferrin receptor

1 reference

12 December 2020

Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors.

1 reference

12 December 2020

Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.

1 reference

12 December 2020

Rapid entry of nicked diphtheria toxin into cells at low pH. Characterization of the entry process and effects of low pH on the toxin molecule

1 reference

12 December 2020

One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell

1 reference

12 December 2020

Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptor

1 reference

12 December 2020

1 reference

12 December 2020

Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme.

1 reference

12 December 2020

Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

Immunotoxin therapy for CNS tumor

1 reference

12 December 2020

Effect of an anti-murine transferrin receptor-ricin A conjugate on bone marrow stem and progenitor cells treated in vitro

1 reference

12 December 2020

FDA approves fusion protein for treatment of lymphoma

1 reference

12 December 2020

10.1007/S11060-013-1157-8

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1011493316

0 references

1 reference